130 related articles for article (PubMed ID: 6281036)
1. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
[TBL] [Abstract][Full Text] [Related]
2. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
Nishimura K; Miyazaki M; Okunishi H; Toda N
Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
[TBL] [Abstract][Full Text] [Related]
3. A new potent inhibitor of converting enzyme: (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid(SA446).
Iso T; Yamauchi H; Suda H; Nakata K; Nishimura K; Iwao J
Jpn J Pharmacol; 1981 Dec; 31(6):875-82. PubMed ID: 6174764
[TBL] [Abstract][Full Text] [Related]
4. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
[TBL] [Abstract][Full Text] [Related]
5. A novel orally active converting-enzyme inhibitor YS 980: effects on blood pressure in spontaneously hypertensive rats.
Unger T; Rockhold RW; Schaz K; Vescel P; Bönner G; Rascher W; Ganten D
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():157s-160s. PubMed ID: 232020
[TBL] [Abstract][Full Text] [Related]
6. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
7. Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Ogihara T; Yoshizawa M; Yasui T; Nakane H; Nakane Y; Saruta T
Jpn Heart J; 1983 Nov; 24(6):975-83. PubMed ID: 6323782
[TBL] [Abstract][Full Text] [Related]
8. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
Nakata K; Takada T; Yamauchi H; Iso T
Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive mechanism of an angiotensin converting enzyme inhibitor, SA446, in dogs.
Nishimura K; Okunishi H; Miyazaki M
Bull Osaka Med Coll; 1989 Nov; 35(1-2):29-37. PubMed ID: 2486241
[TBL] [Abstract][Full Text] [Related]
10. Species difference of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinec arb oxylic acid (SA446) in inhibition of angiotensin converting enzyme.
Nakata K; Iwatani T; Horiuchi M; Kito H; Yamauchi H; Iso T
Jpn J Pharmacol; 1986 Mar; 40(3):367-72. PubMed ID: 3012163
[TBL] [Abstract][Full Text] [Related]
11. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
12. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
13. [Combined effect of (2R, 4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarbo xyl ic acid (SA446) with hydrochlorothiazide or propranolol on development of hypertension in spontaneously hypertensive rats (SHR) by long-term administration].
Takada T; Nakata K; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):331-7. PubMed ID: 3710315
[TBL] [Abstract][Full Text] [Related]
14. [Antihypertensive effects of SA446, hydralazine and the combination on renal hypertensive rats and spontaneously hypertensive rats by long-term treatment].
Nakata K; Nishimura K; Takada T; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):113-21. PubMed ID: 3699625
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
16. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
17. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
18. Brain converting enzyme inhibition: a possible mechanism for the antihypertensive action of captopril in spontaneously hypertensive rats.
Unger T; Kaufmann-Bühler I; Schölkens B; Ganten D
Eur J Pharmacol; 1981 Apr; 70(4):467-78. PubMed ID: 6263638
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
[No Abstract] [Full Text] [Related]
20. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
[Next] [New Search]
